In a measure that flouts the FDA, Florida says doctors can give unapproved stem-cell therapies for wound care, pain ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy ...

Founder, Chief Science Officer and Chairman, Longeveron Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of M ...

A research team led by Professor Jeon Jin-pyeong of Neurosurgery at Chuncheon Sacred Heart Hospital at Hallym University ...

A groundbreaking UCSF study challenges the long-held belief that blood is solely produced in bone marrow. Researchers ...

A study evaluating a pioneering lentivirus (LV)-mediated gene therapy trial for classical Fabry disease showed promising ...

In our modern age, technology has advanced rapidly, encompassing innovations in skin rejuvenation and beauty treatments that ...

The biobank completed HLA typing; a close HLA match between donor and patient greatly reduces the risk of the body rejecting ...

Losing a tooth as an adult is par for the course for many of us. The only option to replace them? Artificial substitutes. But ...

Starting on August 1st, the Wisconsin newborn screening program will be adding two genetic disorders X-ALD and MPS type 1 to their panel.